Logo image of MTZ

MASTEC INC (MTZ) Stock Fundamental Analysis

NYSE:MTZ - New York Stock Exchange, Inc. - US5763231090 - Common Stock - Currency: USD

163.71  -0.95 (-0.58%)

After market: 163.71 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MTZ. MTZ was compared to 51 industry peers in the Construction & Engineering industry. MTZ has an average financial health and profitability rating. MTZ is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

MTZ had positive earnings in the past year.
MTZ had a positive operating cash flow in the past year.
Of the past 5 years MTZ 4 years were profitable.
MTZ had a positive operating cash flow in each of the past 5 years.
MTZ Yearly Net Income VS EBIT VS OCF VS FCFMTZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

1.2 Ratios

MTZ has a Return On Assets (2.41%) which is in line with its industry peers.
MTZ has a Return On Equity (7.41%) which is comparable to the rest of the industry.
MTZ has a better Return On Invested Capital (6.92%) than 62.75% of its industry peers.
MTZ had an Average Return On Invested Capital over the past 3 years of 4.07%. This is significantly below the industry average of 16.60%.
The last Return On Invested Capital (6.92%) for MTZ is above the 3 year average (4.07%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.41%
ROE 7.41%
ROIC 6.92%
ROA(3y)0.55%
ROA(5y)2.49%
ROE(3y)1.65%
ROE(5y)6.81%
ROIC(3y)4.07%
ROIC(5y)5.8%
MTZ Yearly ROA, ROE, ROICMTZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

MTZ has a Profit Margin (1.72%) which is in line with its industry peers.
In the last couple of years the Profit Margin of MTZ has declined.
MTZ has a Operating Margin of 4.16%. This is comparable to the rest of the industry: MTZ outperforms 47.06% of its industry peers.
In the last couple of years the Operating Margin of MTZ has declined.
MTZ has a Gross Margin (13.13%) which is in line with its industry peers.
In the last couple of years the Gross Margin of MTZ has declined.
Industry RankSector Rank
OM 4.16%
PM (TTM) 1.72%
GM 13.13%
OM growth 3Y-13.4%
OM growth 5Y-12.87%
PM growth 3Y-31.6%
PM growth 5Y-24.69%
GM growth 3Y-2.72%
GM growth 5Y-3.06%
MTZ Yearly Profit, Operating, Gross MarginsMTZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MTZ is destroying value.
The number of shares outstanding for MTZ remains at a similar level compared to 1 year ago.
MTZ has more shares outstanding than it did 5 years ago.
The debt/assets ratio for MTZ has been reduced compared to a year ago.
MTZ Yearly Shares OutstandingMTZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MTZ Yearly Total Debt VS Total AssetsMTZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

MTZ has an Altman-Z score of 3.35. This indicates that MTZ is financially healthy and has little risk of bankruptcy at the moment.
MTZ has a better Altman-Z score (3.35) than 64.71% of its industry peers.
The Debt to FCF ratio of MTZ is 2.42, which is a good value as it means it would take MTZ, 2.42 years of fcf income to pay off all of its debts.
MTZ has a Debt to FCF ratio of 2.42. This is in the better half of the industry: MTZ outperforms 72.55% of its industry peers.
MTZ has a Debt/Equity ratio of 0.71. This is a neutral value indicating MTZ is somewhat dependend on debt financing.
The Debt to Equity ratio of MTZ (0.71) is comparable to the rest of the industry.
Although MTZ does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 2.42
Altman-Z 3.35
ROIC/WACC0.68
WACC10.12%
MTZ Yearly LT Debt VS Equity VS FCFMTZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.22 indicates that MTZ should not have too much problems paying its short term obligations.
With a Current ratio value of 1.22, MTZ perfoms like the industry average, outperforming 45.10% of the companies in the same industry.
MTZ has a Quick Ratio of 1.18. This is a normal value and indicates that MTZ is financially healthy and should not expect problems in meeting its short term obligations.
MTZ has a Quick ratio of 1.18. This is comparable to the rest of the industry: MTZ outperforms 47.06% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.18
MTZ Yearly Current Assets VS Current LiabilitesMTZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

MTZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 91.56%, which is quite impressive.
Measured over the past years, MTZ shows a decrease in Earnings Per Share. The EPS has been decreasing by -5.63% on average per year.
The Revenue has been growing slightly by 3.03% in the past year.
The Revenue has been growing by 11.36% on average over the past years. This is quite good.
EPS 1Y (TTM)91.56%
EPS 3Y-11.15%
EPS 5Y-5.63%
EPS Q2Q%492.31%
Revenue 1Y (TTM)3.03%
Revenue growth 3Y15.66%
Revenue growth 5Y11.36%
Sales Q2Q%6%

3.2 Future

The Earnings Per Share is expected to grow by 24.76% on average over the next years. This is a very strong growth
MTZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.69% yearly.
EPS Next Y57.95%
EPS Next 2Y35.74%
EPS Next 3Y28.98%
EPS Next 5Y24.76%
Revenue Next Year12.02%
Revenue Next 2Y10.43%
Revenue Next 3Y9.49%
Revenue Next 5Y7.69%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MTZ Yearly Revenue VS EstimatesMTZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
MTZ Yearly EPS VS EstimatesMTZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 36.06, MTZ can be considered very expensive at the moment.
MTZ's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of MTZ to the average of the S&P500 Index (26.35), we can say MTZ is valued slightly more expensively.
The Price/Forward Earnings ratio is 22.78, which indicates a rather expensive current valuation of MTZ.
The rest of the industry has a similar Price/Forward Earnings ratio as MTZ.
The average S&P500 Price/Forward Earnings ratio is at 22.19. MTZ is around the same levels.
Industry RankSector Rank
PE 36.06
Fwd PE 22.78
MTZ Price Earnings VS Forward Price EarningsMTZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MTZ is valued a bit cheaper than the industry average as 62.75% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MTZ indicates a rather cheap valuation: MTZ is cheaper than 86.27% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 14.05
EV/EBITDA 14.94
MTZ Per share dataMTZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MTZ's earnings are expected to grow with 28.98% in the coming years.
PEG (NY)0.62
PEG (5Y)N/A
EPS Next 2Y35.74%
EPS Next 3Y28.98%

0

5. Dividend

5.1 Amount

MTZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MASTEC INC

NYSE:MTZ (6/20/2025, 8:04:00 PM)

After market: 163.71 0 (0%)

163.71

-0.95 (-0.58%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners73.54%
Inst Owner Change-2.66%
Ins Owners21.42%
Ins Owner Change1.37%
Market Cap12.94B
Analysts81.9
Price Target183.89 (12.33%)
Short Float %1.65%
Short Ratio1.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)32.91%
Min EPS beat(2)16.35%
Max EPS beat(2)49.47%
EPS beat(4)4
Avg EPS beat(4)26.68%
Min EPS beat(4)9.71%
Max EPS beat(4)49.47%
EPS beat(8)7
Avg EPS beat(8)22.85%
EPS beat(12)11
Avg EPS beat(12)16.5%
EPS beat(16)15
Avg EPS beat(16)17.74%
Revenue beat(2)2
Avg Revenue beat(2)2.77%
Min Revenue beat(2)1.55%
Max Revenue beat(2)3.98%
Revenue beat(4)2
Avg Revenue beat(4)-1.41%
Min Revenue beat(4)-6%
Max Revenue beat(4)3.98%
Revenue beat(8)3
Avg Revenue beat(8)-3.01%
Revenue beat(12)6
Avg Revenue beat(12)-1.18%
Revenue beat(16)8
Avg Revenue beat(16)-0.84%
PT rev (1m)4.64%
PT rev (3m)6.99%
EPS NQ rev (1m)0.33%
EPS NQ rev (3m)2.31%
EPS NY rev (1m)-0.01%
EPS NY rev (3m)16.06%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)4.59%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)2.31%
Valuation
Industry RankSector Rank
PE 36.06
Fwd PE 22.78
P/S 1.04
P/FCF 14.05
P/OCF 11.85
P/B 4.49
P/tB N/A
EV/EBITDA 14.94
EPS(TTM)4.54
EY2.77%
EPS(NY)7.19
Fwd EY4.39%
FCF(TTM)11.66
FCFY7.12%
OCF(TTM)13.82
OCFY8.44%
SpS157.66
BVpS36.48
TBVpS-0.19
PEG (NY)0.62
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.41%
ROE 7.41%
ROCE 8.71%
ROIC 6.92%
ROICexc 7.35%
ROICexgc 15.22%
OM 4.16%
PM (TTM) 1.72%
GM 13.13%
FCFM 7.39%
ROA(3y)0.55%
ROA(5y)2.49%
ROE(3y)1.65%
ROE(5y)6.81%
ROIC(3y)4.07%
ROIC(5y)5.8%
ROICexc(3y)4.36%
ROICexc(5y)6.31%
ROICexgc(3y)8.75%
ROICexgc(5y)11.72%
ROCE(3y)5.12%
ROCE(5y)7.29%
ROICexcg growth 3Y1.9%
ROICexcg growth 5Y-5.86%
ROICexc growth 3Y-3.57%
ROICexc growth 5Y-10.58%
OM growth 3Y-13.4%
OM growth 5Y-12.87%
PM growth 3Y-31.6%
PM growth 5Y-24.69%
GM growth 3Y-2.72%
GM growth 5Y-3.06%
F-Score7
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 2.42
Debt/EBITDA 2.06
Cap/Depr 35.99%
Cap/Sales 1.37%
Interest Coverage 2.9
Cash Conversion 110.02%
Profit Quality 430.88%
Current Ratio 1.22
Quick Ratio 1.18
Altman-Z 3.35
F-Score7
WACC10.12%
ROIC/WACC0.68
Cap/Depr(3y)37.77%
Cap/Depr(5y)45.07%
Cap/Sales(3y)1.84%
Cap/Sales(5y)2.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.56%
EPS 3Y-11.15%
EPS 5Y-5.63%
EPS Q2Q%492.31%
EPS Next Y57.95%
EPS Next 2Y35.74%
EPS Next 3Y28.98%
EPS Next 5Y24.76%
Revenue 1Y (TTM)3.03%
Revenue growth 3Y15.66%
Revenue growth 5Y11.36%
Sales Q2Q%6%
Revenue Next Year12.02%
Revenue Next 2Y10.43%
Revenue Next 3Y9.49%
Revenue Next 5Y7.69%
EBIT growth 1Y96.52%
EBIT growth 3Y0.16%
EBIT growth 5Y-2.97%
EBIT Next Year126.74%
EBIT Next 3Y41.1%
EBIT Next 5Y27.66%
FCF growth 1Y944.67%
FCF growth 3Y16.01%
FCF growth 5Y18.08%
OCF growth 1Y712.68%
OCF growth 3Y12.25%
OCF growth 5Y15.31%